Table 2.
Chronological list of placebo controlled drug trials for functional gastrointestinal disorders related to abdominal pain in children and adolescents, including summary of treatment, sample size, and outcome
| Ref. | Treatment | Diagnosis | Sample size (enrolled/completed) | Superior to placebo for pain relief |
| Symon and Russell[44] (1995) | Pitotifen | Abdominal migraine | 16/14 | Yes |
| Kline et al[45] (2001) | Enteric coated peppermint oil capsules | Irritable bowel syndrome | 50/42 | Yes |
| See et al[46] (2001) | Famotidine | Abdominal pain and dyspepsia | 25/25 | Yes |
| Friesen et al[47] (2004) | Montelukast | FD with duodenal eosinophilia | 40/37 | Yes |
| Bahar et al[48] (2008) | Amitriptyline | Irritable bowel syndrome | 35/33 | Yes |
| Sadeghian et al[49] (2008) | Cyproheptadine | Functional abdominal pain | 36/28 | Yes |
| Saps et al[50] (2009) | Amitriptyline | FD, irritable bowel syndrome, and functional abdominal pain | 90/83 | No |
| Pourmoghaddas et al[51] (2014) | Mebeverine | Functional abdominal pain | 115/87 | No |